The prognostic value of the temporal course of S100β protein in post-acute severe brain injury: A prospective and observational study

References

• León-Carrión J, Domínguez-Morales Mdel R, Barroso y Martín JM, Murillo-Cabezas F. Epidemiology of traumatic brain injury and subarachnoid hemorrhage. Pituitary 2005; 8: 197–202
   PubMedGoogle Scholar
• Pelinka LE, Kroepfl A, Schmidhammer R, Krenn M, Buchinger W, Redl H, Raabe A. Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma. The Journal of Trauma 2004; 57: 1006–1012
   PubMed Web of Science ®Google Scholar
• Kochanek PM, Berger RP, Bayir H, Wagner AK, Jenkins LW, Clark RS. Biomarkers of primary and evolving damage in traumatic and ischemic brain injury: Diagnosis, prognosis, probing mechanisms, and therapeutic decision making. Current Opinion in Critical Care 2008; 14: 135–141
   PubMed Web of Science ®Google Scholar
• Petzold A, Green AJ, Keir G, Fairley S, Kitchen N, Smith M, Thompson EJ. Role of serum S100β as an early predictor of high intracranial pressure and mortality in brain injury: A pilot study. Critical Care Medicine 2002; 30: 2705–2710
   PubMed Web of Science ®Google Scholar
• Korfias S, Stranjalis G, Papadimitriou A, Psachoulia C, Daskalakis G, Antsaklis A, Sakas DE. Serum S100β protein as a biochemical marker of brain injury: A review of current concepts. Current Medicinal Chemistry 2006; 13: 3719–3731
   PubMed Web of Science ®Google Scholar
• Bloomfield SM, McKinney J, Smith L, Brisman J. Reliability of S100β in predicting severity of central nervous system injury. Neurocritical Care 2007; 6: 121–138
   PubMed Web of Science ®Google Scholar
• Kleindienst A, Bullock RM. A critical analysis of the role of the neurotrophic protein S100β in acute brain injury. The Journal of Neurotrauma 2006; 8: 1185–1200
   Google Scholar
• Nylén K, Ost M, Csajbok LZ, Nilsson I, Hall C, Blennow K, Nellgård B, Rosengren L. Serum levels of S100β, S100A1B and S100β B are all related to outcome after severe traumatic brain injury. Acta Neurochirurgica 2008; 150: 221–227
   PubMed Web of Science ®Google Scholar
• Herrmann M, Curio N, Jost S, Grubich C, Ebert AD, Fork ML, Synowitz H. Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neuropsychological outcome after traumatic brain injury. Journal of Neurology, Neurosurgery, and Psychiatry 2001; 70: 95–100
   PubMed Web of Science ®Google Scholar
• Woertgen C, Rothoerl RD, Brawanski A. Early S100β serum level correlates to quality of life in patients after severe head injury. Brain Injury 2002; 16: 807–816
   PubMed Web of Science ®Google Scholar
• Berger RP. The use of serum biomarkers to predict outcome after traumatic brain injury in adults and children. Journal of Head Trauma Rehabilitation 2006; 21: 315–333
   PubMed Web of Science ®Google Scholar
• Raabe A, Grolms C, Sorge O, Zimmermann M, Seifert V. Serum S-100B protein in severe head injury. Neurosurgery 1999; 45: 477–483
   PubMed Web of Science ®Google Scholar
• Korfias S, Stranjalis G, Boviatsis E, Psachoulia C, Jullien G, Gregson B, Mendelow AD, Sakas DE. Serum S100β protein monitoring in patients with severe traumatic brain injury. Intensive Care Medicine 2007; 33: 255–260
   PubMed Web of Science ®Google Scholar
• Civil L, Schawab W. The abbreviated injury scale, revision 1985. A condensed chart for clinical use. The Journal of Trauma 1988; 28: 87–90
   PubMed Web of Science ®Google Scholar
• Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbals WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644–1655
   Google Scholar
• Baker SP, O’Neill B, Haddon W, Jr, Long WB. The Injury Severity Score: A method for describing patients with multiple injuries and evaluating emergency care. The Journal of Trauma 1974; 14: 187–196
   PubMed Web of Science ®Google Scholar
• Marshall LF, Bowers Marshall S, Klauber MR, van Berkum Clark M, Eisenberg HM, Jane JA, Luerssen TG, Marmarou A, Foulkes MA. A new classification of head injury based on computerized tomography. Journal of Neurosurgery 1991; 75 (Suppl): S14–S20
   Web of Science ®Google Scholar
• Leal-Noval SR, Muñoz-Gómez M, Arellano-Orden V, Marín-Caballos A, Amaya-Villar R, Marín A, Puppo-Moreno A, Ferrándiz-Millón C, Flores-Cordero JM, Murillo-Cabezas F. Impact of age of transfused blood on cerebral oxygenation in male patients with severe traumatic brain injury. Critical Care Medicine 2008; 36: 1290–1296
   PubMed Web of Science ®Google Scholar
• Marín-Caballos AJ, Murillo-Cabezas F, Cayuela-Domínguez A, Domínguez-Roldán JM, Rincón-Ferrari MD, Valencia-Anguita J, Flores-Cordero JM, Muñoz-Sánchez MA. Cerebral perfusion pressure and risk of brain hypoxia in severe head injury: A prospective observational study. Critical Care 2005; 9: R670–R676
   Web of Science ®Google Scholar
• Jennet B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975; 1: 480–484
   PubMed Web of Science ®Google Scholar
• Alber B, Hein R, Garbe C, Caroli U, Luppa PB. Multicenter evaluation of the analytical and clinical performance of the Elecsys S100 immunoassay in patients with malignant melanoma. Clinical Chemistry and Laboratory Medicine 2005; 43: 557–563
   PubMed Web of Science ®Google Scholar
• Biberthaler P, Linsenmeier U, Pfeifer KJ, Kroetz M, Mussack T, Kanz KG, Hoecherl EF, Jonas F, Marzi I, Leucht P, et al. Serum S100β concentration provides additional information for the indication of computed tomography in patients after minor head injury: A prospective multicenter study. Shock 2006; 25: 446–453
   PubMed Web of Science ®Google Scholar
• Nagelkerke NJD. A note on a general definition of the coefficient of determination. Biometrika 1991; 78: 691–692
   Web of Science ®Google Scholar
• Hanley JA, McNeil BJ. A method of comparing the areas under the receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839–843
   PubMed Web of Science ®Google Scholar
• Bishop YMM, Fienberg SE, Holland PW. Discrete multivariate analysis: Theory and practise. MIT Press, Cambridge, MA 1975
   Google Scholar
• Vos PE, Lamers KJ, Hendriks JC, van Haaren M, Beems T, Zimmerman C, van Geel W, de Reus H, Biert J, Verbeek MM. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology 2004; 62: 1303–1310
   PubMed Web of Science ®Google Scholar
• Dimopoulou I, Korfias S, Dafni U, Anthi A, Psachoulia C, Jullien G, Sakas DE, Roussos C. Protein S-100b serum levels in trauma-induced brain death. Neurology 2003; 60: 947–951
   PubMed Web of Science ®Google Scholar
• McKeating EG, Andrews PJ, Mascia L. Relationship of neuron specific enolase and protein S-100 concentrations in systemic and jugular venous serum to injury severity and outcome after traumatic brain injury. Acta Neurochirurgica Supplement 1998; 71: 117–119
   PubMedGoogle Scholar
• Ingebrigtsen T, Romner B, Marup-Jensen S, Dons M, Lundqvist C, Bellner J, Alling C, Børgesen SE. The clinical value of serum S-100 protein measurements in minor head injury: A Scandinavian multicentre study. Brain Injury 2000; 14: 1047–1055
   PubMed Web of Science ®Google Scholar
• Maas AIR, Stocchetti N, Bulock R. Moderate and severe traumatic brain injury in adults. Lancet Neurology 2008; 7: 728–741
   PubMed Web of Science ®Google Scholar
• Pelinka LE, Kroepfl A, Leixnering M, Buchinger W, Raabe A, Redl H. GFAP versus S100β in serum after traumatic brain injury: Relationship to brain damage and outcome. Journal of Neurotrauma 2004; 21: 1553–1561
   PubMed Web of Science ®Google Scholar